Viewing Study NCT02255461


Ignite Creation Date: 2025-12-24 @ 12:39 PM
Ignite Modification Date: 2026-01-28 @ 4:18 AM
Study NCT ID: NCT02255461
Status: TERMINATED
Last Update Posted: 2021-03-02
First Post: 2014-09-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Sponsor: Pediatric Brain Tumor Consortium
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Childhood Choroid Plexus Tumor View
None Childhood Ependymoblastoma View
None Childhood Grade III Meningioma View
None Childhood High-grade Cerebellar Astrocytoma View
None Childhood High-grade Cerebral Astrocytoma View
None Childhood Medulloepithelioma View
None Recurrent Childhood Anaplastic Astrocytoma View
None Recurrent Childhood Anaplastic Oligoastrocytoma View
None Recurrent Childhood Anaplastic Oligodendroglioma View
None Recurrent Childhood Brain Stem Glioma View
None Recurrent Childhood Cerebellar Astrocytoma View
None Recurrent Childhood Cerebral Astrocytoma View
None Recurrent Childhood Giant Cell Glioblastoma View
None Recurrent Childhood Glioblastoma View
None Recurrent Childhood Gliomatosis Cerebri View
None Recurrent Childhood Gliosarcoma View
None Recurrent Childhood Medulloblastoma View
None Recurrent Childhood Pineoblastoma View
None Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor View
Keywords: